Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry

OBJECTIVES: To investigate the safety and clinical efficacy of tirofiban during primary percutaneous coronary interventions (pPCI). BACKGROUND: Gp IIb/IIIa inhibitors (GPI) use during pPCI has declined over years, mainly for the increased hemorrhagic risk associated to their use and for the availabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigattieri, Stefano, Lettieri, Corrado, Tiberti, Gianluca, Romano, Michele, Ferlini, Marco, Testa, Luca, Pierini, Simona, Ettori, Federica, Passamonti, Enrico, Marchese, Alfredo, Musumeci, Giuseppe, Esposito, Giovanni, Tarantini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983258/
https://www.ncbi.nlm.nih.gov/pubmed/35418809
http://dx.doi.org/10.1155/2022/9609970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983258/
https://www.ncbi.nlm.nih.gov/pubmed/35418809
http://dx.doi.org/10.1155/2022/9609970

Ejemplares similares